Ascletis Gets Record Funding From China’s Hangzhou Development Zone For HIV/AIDs Drug Research
By
Ying Huang / Email the Author / PharmAsia News Feb. 1, 2012 1:16 PM GMT
China / Word Count: 938 / Article # 28120130001
Executive Summary
Hangzhou National Hi-Tech Industrial Development Zone awarded U.S.-China hybrid Ascletis a $1.6 million grant to fund research for HIV/AIDs drugs, the highest amount paid to date by a program aimed at wooing top Chinese national research talent back home.
$50.00
Buy Now
For $50.00, purchase this 938-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.